China’s BYD poised to overtake Tesla as world’s top EV seller for the first time

China’s BYD poised to overtake Tesla as world’s top EV seller for the first time


Imported BYD vehicles are parked at a port on March 27, 2025 in Yokohama, Japan.

Tomohiro Ohsumi | Getty Images News | Getty Images

Chinese auto giant BYD on Friday is expected to dethrone U.S. rival Tesla as the world’s biggest seller of electric vehicles on a calendar-year basis.

The milestone would cap an extraordinary rise for BYD, a company Tesla’s Elon Musk once dismissed by laughing at their products during a 2011 Bloomberg interview.

The two carmakers are poised to publish their final annual sales figures for 2025, although based on available sales data, it appears all but certain that BYD will officially surpass Tesla.

In a statement published Thursday, BYD said sales of its battery-powered cars rose nearly 28% to 2.26 million units. Tesla has not yet released its 2025 sales figures, although it is expected to do so later in the day.

On Monday, Tesla compiled an average estimate for 1.6 million vehicle deliveries in 2025, down roughly 8% from 2024, putting the company on track for its second straight annual drop.

Deliveries are the closest approximation of sales reported by Tesla, but are not precisely defined in the company’s shareholder communications.

Tesla has endured a roller-coaster ride this year. The company saw shares collapse in the first quarter of 2025 amid stiff competition, particularly from Chinese EV manufacturers, and reputational fallout from Musk’s incendiary political rhetoric.

The stock price has come roaring back in recent weeks, however, notching an all-time closing high of $489.88 last month, after Musk said the company had been testing driverless vehicles in Austin, Texas, with no occupants on board, almost six months after launching a pilot program with safety drivers.

— CNBC’s Lora Kolodny contributed to this report.



Source

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson’s treatment
World

Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson’s treatment

Kelvn | Istock | Getty Images Shares of Japanese drugmaker Sumitomo Pharma fell over 12% Friday on what appeared to be profit-taking, a day after the government endorsed the company’s iPS cell-based therapy for Parkinson’s and heart disease. The decision is a milestone in Japan’s years-long effort to cultivate a homegrown sector focused on cutting-edge […]

Read More
Japan inflation falls below BOJ’s 2% target for first time since March 2022
World

Japan inflation falls below BOJ’s 2% target for first time since March 2022

Shop owners of a 70-year-old “takoyaki”, or octopus balls, restaurant chat while cooking along a street in the Taito Ward area of Tokyo on February 21, 2025. Richard A. Brooks | Afp | Getty Images Japan’s headline inflation rate fell to 1.5% in January, its lowest level since March 2022. The reading ended a run […]

Read More
CNBC Daily Open: Private credit fears and U.S.-Iran tensions pressure Wall Street
World

CNBC Daily Open: Private credit fears and U.S.-Iran tensions pressure Wall Street

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Feb. 19, 2026. Brendan McDermid | Reuters U.S. markets had a shaky Thursday, pressured by Washington’s escalating tensions with Iran and renewed worries over private credit. White House press secretary Karoline Leavitt said Wednesday that there were “many […]

Read More